A BACwards glance at neurodegeneration: Molecular insights into disease from LRRK2, SNCA and MAPT BAC-transgenic mice

Biochemical Society Transactions

Volumn 39, Issue 4, 2011, Pages 862-867

  Johnson, Sara J ^a   Wade Martins, Richard ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

synuclein; Bacterial artificial chromosome transgenics (BAC transgenics); Leucinerich repeat kinase 2 (LRRK2); Microtubule associated protein tau; Neurodegeneration; Parkinson's disease

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; ALPHA SYNUCLEIN; FATTY ACID; LEUCINE RICH REPEAT KINASE 2; MESSENGER RNA; NEUROTRANSMITTER; TAU PROTEIN; TYROSINE 3 MONOOXYGENASE;

ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL MODEL; BACTERIAL ARTIFICIAL CHROMOSOME; BRAIN REGION; CONFERENCE PAPER; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; FATTY ACID METABOLISM; FRONTOTEMPORAL DEMENTIA; GENE; GENE EXPRESSION; GENE MUTATION; GENETIC MODEL; GENETIC VARIABILITY; HISTOLOGY; HUMAN; HYPERACTIVITY; HYPOSMIA; IMMOBILIZATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOTOR PERFORMANCE; MOUSE STRAIN; NERVE DEGENERATION; NERVE FIBER; NONHUMAN; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN EXPRESSION; PYRIFORM CORTEX; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TAUOPATHY; TRANSGENE; TRANSGENICS; WESTERN BLOTTING; WILD TYPE;

ALPHA-SYNUCLEIN; ANIMALS; CHROMOSOMES, ARTIFICIAL, BACTERIAL; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, TRANSGENIC; MUTATION; PARKINSON DISEASE; PROTEIN-SERINE-THREONINE KINASES; TAU PROTEINS;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS MUSCULUS;

EID: 79960880757     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0390862     Document Type: Conference Paper

References (31)

1. Gordon, J.W., Scangos, G.A. and Plotkin, D.J. (1980) Genetic transformation of mouse embryos by microinjection of purified DNA. Proc. Natl. Acad. Sci. U.S.A. 77, 7380-7384
2. Dauer, W. and Ho, C.C. (2010) The biology and pathology of the familial Parkinson's disease protein LRRK2. Mov. Disord. 25, S40-S43, Suppl. 1
3. Correia Guedes, L., Ferreira, J.J., Rosa, M.M., Coelho, M., Bonifati, V. and Sampaio, C. (2010) Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: a systematic review. Parkinsonism Relat. Disord. 16, 237-242
4. Gandhi, P.N., Chen, S.G. and Wilson-Delfosse, A.L. (2009) Leucine-rich repeat kinase 2 (LRRK2): a key player in the pathogenesis of Parkinson's disease. J. Neurosci. Res. 87, 1283-1295
5. Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R.J., Calne, D.B. et al. (2004) Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology. Neuron 44, 601-607 (Pubitemid 39531225)
6. Higashi, S., Biskup, S., West, A.B., Trinkaus, D., Dawson, V.L., Faull, R.L.M., Waldvogel, H.J., Arai, H., Dawson, T.M., Moore, D.J. and Emson, P.C. (2007) Localization of Parkinson's disease-associated LRRK2 in normal and pathological human brain. Brain Res. 1155, 208-219 (Pubitemid 46900930)
7. Miklossy, J., Arai, T., Guo, J.P., Klegeris, A., Yu, S., McGeer, E.G. and McGeer, P.L. (2006) LRRK2 expression in normal and pathologic human brain and in human cell lines. J. Neuropathol. Exp. Neurol. 65, 953-963
8. Alegre-Abarrategui, J., Ansorge, O., Esiri, M. and Wade-Martins, R. (2008) LRRK2 is a component of granular α-synuclein pathology in the brainstem of Parkinson's disease. Neuropathol. Appl. Neurobiol. 34, 272-283
9. Melrose, H.L., Kent, C.B., Taylor, J.P., Dachsel, J.C., Hinkle, K.M., Lincoln, S.J., Mok, S.S., Culvenor, J.G., Masters, C.L., Tyndall, G.M. et al. (2007) A comparative analysis of leucine-rich repeat kinase 2 (Lrrk2) expression in mouse brain and Lewy body disease. Neuroscience 147, 1047-1058 (Pubitemid 47102551)
10. Li, X., Patel, J.C., Wang, J., Avshalumov, M.V., Nicholson, C., Buxbaum, J.D., Elder, G.A., Rice, M.E. and Yue, Z. (2010) Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S. J. Neurosci. 30, 1788-1797
11. R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease. Nat. Neurosci. 12, 826-828
12. Melrose, H., Lincoln, S., Tyndall, G., Dickson, D. and Farrer, M. (2006) Anatomical localization of leucine-rich repeat kinase 2 in mouse brain. Neuroscience 139, 791-794 (Pubitemid 44308089)
13. Ibáñez, P., Bonnet, A.M., Débarges, B., Lohmann, E., Tison, F., Pollak, P., Agid, Y., Dürr, A. and Brice, P.A. (2004) Causal relation between α-synuclein gene duplication and familial Parkinson's disease. Lancet 364, 1169-1171 (Pubitemid 39296605)
14. Chartier-Harlin, M.C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M. et al. (2004) α-Synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 364, 1167-1169 (Pubitemid 39296604)
15. Venda, L.L., Cragg, S.J., Buchman, V.L. and Wade-Martins, R. (2010) α-Synuclein and dopamine at the crossroads of Parkinson's disease. Trends Neurosci. 33, 559-568
16. Ruipérez, V., Darios, F. and Davletov, B. (2010) α-Synuclein, lipids and Parkinson's disease. Prog. Lipid Res. 49, 420-428
17. Beyer, K. (2006) α-Synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers. Acta Neuropathol. 112, 237-251
18. Kuo, Y.M., Li, Z., Jiao, Y., Gaborit, N., Pani, A.K., Orrison, B.M., Bruneau, B.G., Giasson, B.I., Smeyne, R.J., Gershon, M.D. and Nussbaum, R.L. (2010) Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated α-synuclein gene mutations precede central nervous system changes. Hum. Mol. Genet. 19, 1633-1650
19. Ansari, K.A. and Johnson, A. (1975) Olfactory function in patients with Parkinson's disease. J. Chronic Dis. 28, 493-497
20. Edwards, L.L., Quigley, E.M.M. and Pfeiffer, R.F. (1992) Gastrointestinal dysfunction in Parkinson's disease: frequency and pathophysiology. Neurology 42, 726-732
21. Parsian, A.J., Racette, B.A., Zhao, J.H., Sinha, R., Patra, B., Perlmutter, J.S. and Parsian, A. (2007) Association of α-synuclein gene haplotypes with Parkinson's disease. Parkinsonism Relat. Disord. 13, 343-347
22. Cronin, K.D., Ge, D., Manninger, P., Linnertz, C., Rossoshek, A., Orrison, B.M., Bernard, D.J., El-Agnaf, O.M.A., Schlossmacher, M.G., Nussbaum, R.L. and Chiba-Falek, O. (2009) Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human α-synuclein in transgenic mouse brain. Hum. Mol. Genet. 18, 3274-3285
23. Simón-Sánchez, J., Schulte, C., Bras, J.M., Sharma, M., Gibbs, J.R., Berg, D., Paisan-Ruiz, C., Lichtner, P., Scholz, S.W., Hernandez, D.G. et al. (2009) Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet. 41, 1308-1312
24. Iqbal, K., Liu, F., Gong, C.X., del Alonso, A.C. and Grundke-Iqbal, I. (2009) Mechanisms of tau-induced neurodegeneration. Acta Neuropathol. 118, 53-69
25. Lee, V.M.Y., Goedert, M. and Trojanowski, J.Q. (2001) Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121-1159
26. Goedert, M., Spillantini, M.G., Jakes, R., Rutherford, D. and Crowther, R.A. (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3, 519-526
27. Duff, K., Knight, H., Refolo, L.M., Sanders, S., Yu, X., Picciano, M., Malester, B., Hutton, M., Adamson, J., Goedert, M. et al. (2000) Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes. Neurobiol. Dis. 7, 87-98
28. Andorfer, C., Kress, Y., Espinoza, M., De Silva, R., Tucker, K.L., Barde, Y.A., Duff, K. and Davies, P. (2003) Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. J. Neurochem. 86, 582-590 (Pubitemid 36897439)
29. Andorfer, C., Acker, C.M., Kress, Y., Hof, P.R., Duff, K. and Davies, P. (2005) Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms. J. Neurosci. 25, 5446-5454 (Pubitemid 40770926)
30. Geschwind, D. (2004) GENSAT: a genomic resource for neuroscience research. Lancet Neurol. 3, 82
31. Heintz, N. (2004) Gene expression nervous system atlas (GENSAT). Nat. Neurosci. 7, 483